Navigation Links
NOVAVAX and the University of Massachusetts Medical School Announce Preclinical Study Results for a Respiratory Syncytial Virus ('RSV') Vaccine Candidate
Date:12/9/2008

ROCKVILLE, Md., Dec. 9 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) and the University of Massachusetts Medical School announced results from a preclinical study of a Respiratory Syncytial Virus ("RSV") vaccine candidate. Novavax has licensed exclusive worldwide rights from the University of Massachusetts Medical School to certain technology for the development and commercialization of Paramyxovirus vaccines incorporating certain Virus-Like-Particles ("VLPs"). This vaccine candidate is Novavax's first recombinant VLP for the prevention of RSV disease.

The preclinical study evaluated the immunogenicity and efficacy of the RSV VLP vaccine candidate in mice. The VLP contains the matrix (i.e., "core") protein of Newcastle Disease Virus decorated with a human RSV attachment glycoprotein (Ga), which is important for inducing immunity against RSV. In this study, mice were immunized with one of four doses of the RSV VLP vaccine candidate, inactivated RSV, live RSV, or a placebo. The antibody responses to the RSV VLPs were robust and higher than the antibody responses to inactivated or live RSV. Further, antibody titers increased with higher VLP doses.

Subsets of mice that had been immunized with either RSV VLPs via intraperitoneal inoculation or live RSV via intranasal inoculation received a vaccine booster dose and were challenged with live RSV intra-nasally. Unimmunized mice were evaluated as controls. The VLP-immunized mice were protected from RSV replication in the lungs. Further, the lung tissue of these mice showed no evidence of enhanced inflammation after RSV challenge/infection, which has been reported with a formalin-inactivated RSV vaccine.

In summary, the candidate VLP vaccine induced strong antibody responses against RSV, protected mice against RSV replication i
'/>"/>

SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Novavax to Present Seasonal Influenza Data Results in an Investor Conference Call on December 11, 2008
2. Novavax CEO to Present at Piper Jaffray 20th Annual Healthcare Conference
3. Novavax CEO to Present at Lazard Capital Markets 5th Annual Healthcare Conference
4. Novavax Announces Release Date of 2008 Third Quarter Financial Results and Investor Conference Call
5. Novavax CEO to Present at Oppenheimer 19th Annual Healthcare Conference
6. Novavax CEO to Present at BIO Investor Forum 2008
7. Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial
8. Novavax Commences Clinical Testing of its Seasonal Influenza VLP Vaccine Candidate
9. Novavax Announces Closing of $18 Million Registered Direct Offering
10. Novavax Announces Pricing of $18 Million Financing of Common Stock and Warrants
11. Novavax to Join Russell 3000 Index
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... CA (PRWEB) June 18, 2013 Tabletop ... standard size SEMs but have limited performance and capability ... resolution. Full size SEMs would normally provide better imaging ... knowledge to operate and have a higher cost of ... address the gap between these two types of SEM ...
(Date:6/18/2013)... June 18, 2013 (PRWEB) June 18, 2013 ... and attendance system in North America, has introduced ... employee data and payroll records between ExakTime’s software ... automates ExakTime software setup and keeps employee ... employee data from a business’ current payroll software, ...
(Date:6/18/2013)... 2013 DuPont welcomes 48 of the ... DuPont National AgriScience Teachers Ambassador Academy this week (NATAA) ... Md. , The NATAA “Ag Academy” is ... a special project of the National FFA Foundation ... (NAAE) . The highly recommended agriscience teachers, who ...
(Date:6/18/2013)... June 18, 2013  regulated information — Global biopharmaceutical ... today announced the launch of a new Pledge ... The Pledge empowers the millions ... and make a personal commitment to demand more: greater ... care team and additional partial-onset seizure control.  More information ...
Breaking Biology Technology:Nanounity Introduces the Pemtron Range of Compact Scanning Electron Microscopes 2Nanounity Introduces the Pemtron Range of Compact Scanning Electron Microscopes 3ExakTime Introduces AccountLinx Plus 2DuPont Sponsors National AgriScience Ambassador Academy 2DuPont Sponsors National AgriScience Ambassador Academy 3Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 2Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 3Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 4Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 5Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 6
... N.J., March 22, 2011 VENENUM Biodesign, a drug ... its compound collection to identify hits against its novel ... it will be exhibiting at the 17th SBS Annual ... Convention Center in Orlando, Florida, March 27-31, 2011. VENENUM ...
... sensor that opens up new ways to detect a ... to hidden explosives. The sensor, which is ... on a completely new architecture and fabrication technique developed ... generated by the scattering of laser light from a ...
... March 21, 2011 Coinstar, Inc. (Nasdaq: ... in SoloHealth, a consumer-driven healthcare technology company that ... including its award-winning EyeSite® product and the next-generation ... "As a leader in automated retail, ...
Cached Biology Technology:VENENUM Biodesign to Exhibit at SBS 2Princeton engineers make breakthrough in ultra-sensitive sensor technology 2Princeton engineers make breakthrough in ultra-sensitive sensor technology 3Coinstar to Invest in SoloHealth 2Coinstar to Invest in SoloHealth 3
(Date:6/18/2013)... , June 19, 2013  Paris Air ... as Geotest-Marvin Test Systems) , a leading provider ... aerospace industries, is demonstrating its solutions this week ... booth 3-C82. With growing challenges including increasingly complex ... demanding efficient, feature-rich, specialized aerospace test solutions that ...
(Date:6/18/2013)... Calgary,s Faculty of Medicine have discovered a mechanism that ... Platelets, a component of blood typically associated with clotting, ... upon detection, seal it off from the rest of ... Nature Immunology this week, provide the science community ... community has known that platelets do participate in immunity, ...
(Date:6/18/2013)... the United Kingdom, the Energy Department,s National Renewable ... have recently published a paper describing a novel ... Limnoria quadripunctata , commonly known as the gribble. ... exhibit a relatively unique ability to produce their ... break down the biomass they eat. New biomass-degrading ...
Breaking Biology News(10 mins):Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 2Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 3Immunity mechanism discovered 2Novel enzyme from tiny gribble could prove a boon for biofuels research 2
... restriction in an environment that promotes overeating and inactivity ... This behavior may contribute to the increased risk ... hours, according to a research abstract that will be ... Meeting of the Associated Professional Sleep Societies (APSS). ...
... YORK (June 10, 2008) The Wildlife Conservation Society ... del Fuego to help protect the guanaco a ... herds from the Andean Plateau to the steppes of Patagonia., ... million animals that live in highly fragmented populations due to ...
... developed at The University of Texas at Austin that ... response has been used to create acellular nerve grafts ... also shows early promise of the detergent solution having ... solution combined with an enzyme treatment conceived at ...
Cached Biology News:Sleep restriction results in increased consumption of energy from snacks 2Study of guanacos launched in Chile 2Engineer develops detergent to promote peripheral nerve healing 2